Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin

Journal of Molecular Biology

Volumn 294, Issue 5, 1999, Pages 1375-1385

  Nilsson, Melanie R ^a   Raleigh, Daniel P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Amylin; Amyloid formation; Diabetes; Islet amyloid polypeptide (IAPP); Protein aggregation

Indexed keywords

AMYLIN; AMYLOID; PEPTIDE;

ARTICLE; BETA SHEET; HUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0033579545     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3286     Document Type: Article

References (29)

1. Ashburn T. T., Han H., McGuinness B. F., Peter T., Lansbury J. Amyloid probes based on Congo red distinguish between fibrils comprising different peptides. Chem. Biol. 3:1996;351-358.
2. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F., Caughey W. S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry. 30:1991;7672-7680.
3. Chirgadze Y. N., Shestopalov B. V., Venyaminov S. Y. Intensities and other spectral parameters of infrared amide bands of polypeptides in the β- and random forms. Biopolymers. 12:1973;1337-1351.
4. Chirgadze Y. N., Fedorov O. V., Trushina N. P. Estimation of amino acid residue side-chain absorption in the infrared spectra of protein solutions in heavy water. Biopolymers. 14:1975;679-694.
5. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C. M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA. 96:1999;3590-3594.
6. Christmanson L., Betsholtz C., Leckström A., Engström U., Cortie C., Johnson K. H., Adrian T. E., Westermark P. Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabetologia. 36:1993;183-188.
7. Cort J., Liu Z., Lee G., Harris S. M., Prickett K. S., Gaeta L. S. L., Andersen N. H. β-structure in human amylin and two designer β-peptides: CD and NMR spectroscopic comparisons suggest soluble β-oligomers and the absence of significant populations of β-strand dimers. Biochem. Biophys. Res. Commun. 204:1994;1088-1095.
8. Deléage G., Geourjon C. An interactive graphic program for calculating the secondary structure content of proteins from circular dichroism spectrum. Comput. Appl. Biosci. 9:1993;197-199.
9. Fabian H., Choo L.-P., Szendrei G. I., Jackson M., Halliday W. C. Jr, L O., Mantsch H. H. Infrared spectroscopic characterization of Alzheimer plaques. Appl. Spectrosc. 47:1993;1513-1518.
10. Glenner G. G. The bases of the staining of amyloid fibers: their physico-chemical nature and the mechanism of their dye-substrate interaction. Progr. Histochem. Cytochem. 13:1981;1-35.
11. Goldsbury C. S., Cooper G. J. S., Goldie K. N., Müller S. A., Saafi E. L., Gruijters W. T. M., Misur M. P., Engel A., Aebi U., Kistler J. Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 119:1997;17-27.
12. Jackson M., Mantsch H. H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30:1995;95-120.
13. Jarrett J. T., Berger E. P., Peter T., Lansbury J. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
14. Johnson K. H., Jordan K., O'Brien T. D., Murtaugh M. P., Wernstedt C., Betsholtz C., Westermark P. Factors affecting diabetogenesis and amyloidogenesis are provided by studies of IAPP in the dog and cat. Natvig J. B. Amyloid Amyloidosis Int. Symp., Sweden. 1990;445-448 Kluwer, Dordrecht.
15. Kaneko I., Tutumi S. Conformations of β-amyloid in solution. J. Neurochem. 68:1997;438-439.
16. Kitamoto T., Muramoto T., Hilbich C., Beyreuther K., Tateishi J. N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome. Brain Res. 545:1991;319-321.
17. Leighton B., Cooper G. J. S. The role of amylin in the insulin resistance of non-insulin-dependent diabetes mellitus. Trends Biochem. Sci. 8:1990;295-298.
18. LeVine H. Thioflavin T interactions with amyloid β-sheet structures. Amyloid: Int. J Exp. Clin. Invest. 2:1995;1-6.
19. Lorenzo A., Razzaboni B., Weir G. C., Yankner B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368:1994;756-760.
20. Middaugh C. R., Mach H., Ryan J. A., Sanyal G., Volkin D. B. Infrared spectroscopy. Shirley B. A. Methods in Molecular Biology Protein Stability and Folding; Theory and Practice. 1995;Humana Press Inc. Totowa.
21. Miyazato M., Nakazato M., Shiomi K., Aburaya J., Toshimori H., Kangawa K., Matsuo H., Matsukura S. Identification and characterization of islet amyloid polypeptide in mammalian gastrointestinal tract. Biochem. Biophys. Res. Commun. 181:1991;293-300.
22. Miyazato M., Nakazato M., Shiomi K., Aburaya J., Kangawa K., Matsuo H., Matsukura S. Molecular forms of islet amyloid polypeptide (IAPP/amylin) in four mammals. Diabetes Res. Clin. Pract. 15:1992;31-36.
23. Moriarty D. F., Raleigh D. P. Effects of sequential proline substitutions on amyloid formation by human amylin 20-29. Biochemistry. 38:1999;1811-1818.
24. Nakazato M., Miyazato M., Asai J., Mitsukawa T., Kangawa K., Matsuo H., Matsukura S. Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation. Biochem. Biophys. Res. Commun. 169:1990;713-718.
25. Sipe J. D. Amyloidosis. Crit. Rev. Clin. Lab. Sci. 31:1994;325-354.
26. Skowronek M., Stopa B., Konieczny L., Rybarska J., Piekarska B., Szneler E., Bakalarski G., Roterman I. Self-assembly of Congo Red - a theoretical and experimental approach to identify its supramolecular organization in water and salt solutions. Biopolymers. 46:1998;267-281.
27. Westermark P. Classification of amyloid fibril proteins and their precursors: an ongoing discussion. Amyloid: Int. J Exp. Clin. Invest. 4:1997;216-218.
28. Westermark R., Engström U., Johnson K. H., Westermark G. T., Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl Acad. Sci. USA. 87:1990a;5036-5040.
29. Westermark P., Johnson K. H., Engström U., Westermark G. T., Dominguez H., Christmansson L., Betsholtz C. Islet amyloid polypeptide: synthetic peptides for study of the pathogenesis of islet amyloid. Natvig J. B. Amyloid Amyloidosis Int. Symp., Sweden. 1990b;449-453 Kluwer, Dordrecht.